795 related articles for article (PubMed ID: 8134850)
1. Pharmacologic management of obsessive-compulsive disorder.
Jackson CW; Morton WA; Lydiard RB
South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Flament MF; Bisserbe JC
J Clin Psychiatry; 1997; 58 Suppl 12():18-22. PubMed ID: 9393392
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of obsessive compulsive disorder.
Goodman WK; McDougle CJ; Price LH
J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
[TBL] [Abstract][Full Text] [Related]
4. The pharmacotherapy of obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH
Pharmacopsychiatry; 1993 May; 26 Suppl 1():24-9. PubMed ID: 8378419
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
6. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL; McDougle CJ; Epperson CN; Price LH
Drug Saf; 1996 Aug; 15(2):116-34. PubMed ID: 8884163
[TBL] [Abstract][Full Text] [Related]
7. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Koran LM; Mueller K; Maloney A
J Clin Psychopharmacol; 1996 Jun; 16(3):253-4. PubMed ID: 8784659
[No Abstract] [Full Text] [Related]
8. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
[TBL] [Abstract][Full Text] [Related]
10. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Todorov C; Freeston MH; Borgeat F
Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic therapy of obsessive compulsive disorder.
DeVeaugh-Geiss J
Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Serlin RC
Arch Gen Psychiatry; 1995 Jan; 52(1):53-60. PubMed ID: 7811162
[TBL] [Abstract][Full Text] [Related]
13. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Maina G; Albert U; Salvi V; Bogetto F
J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
[TBL] [Abstract][Full Text] [Related]
14. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
Chouinard G
Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
[TBL] [Abstract][Full Text] [Related]
15. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
16. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
17. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
Lydiard RB
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
[TBL] [Abstract][Full Text] [Related]
18. A review of pharmacologic treatments for obsessive-compulsive disorder.
Kaplan A; Hollander E
Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
[TBL] [Abstract][Full Text] [Related]
19. OCD: where the serotonin selectivity story begins.
Pigott TA
J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
[TBL] [Abstract][Full Text] [Related]
20. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
